Technology | October 14, 2011

Hologic Features Next Generation Multi-lumen Brachytherapy Applicator

Should cancer be detected in its early stages, many women are candidates for Hologic's targeted radiation therapy, a patient-friendly and effective alternative for women that qualify. At RSNA 2011, Hologic will feature its next generation MammoSite multi-lumen (ML) brachytherapy applicator.

For women with early-stage breast cancer, Hologic offers today’s most widely used form of partial breast irradiation: MammoSite five-day targeted radiation therapy. MammoSite therapy gives physicians an important tool for the practice of breast-conserving therapy, and it makes it easier for more women to consider the choice of lumpectomy, including some women who may have otherwise had a mastectomy to avoid lengthy conventional radiation therapy. Hologic continues to expand the horizon of Accelerated Partial Breast Irradiation (APBI) for early-stage breast cancer patients with its next generation MammoSite multi-lumen (ML) brachytherapy applicator. The MammoSite ML technology enables the ability to shift the radiation dose for a more precise target. This feature will result in more women being appropriate candidates for APBI.

For more information:

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...